National Heart, Lung, and Blood Institute – Training/Institutional

CFDA 93.HL7 Active Grant

Program Funding

Annual program obligations reported to SAM.gov.

Latest annual funding (estimated)
$90.1M FY2026
$92.5M
FY24
$85.3M
FY25
$90.1M
FY26*
* estimated

Program Objective

The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, blood, and sleep conditions and enhance the health of all individuals so that they can live longer and more fulfilling lives. NHLBI supports institutional training programs to develop scientific investigators in these areas.

Eligibility

Eligible Applicants

  • Local
  • Nonprofit Organization
  • Unrestricted by Individual Type
  • For-Profit Organization
  • Not-for-Profit Organization

Local (includes State-designated Indian Tribes; excludes institutions of higher education and hospitals), Public nonprofit institution/organization (includes institutions of higher education and hospitals), Individual/Family, Small business (less than 500 employees), Private nonprofit institution/organization (includes institutions of higher education and hospitals). Any nonprofit organization engaged in biomedical research and institutions or companies organized for profit may apply for almost any kind of grant. To be eligible for funding, a grant application must be approved for scientific merit and program relevance by a scientific review group and a national advisory council.

Beneficiaries

  • Unrestricted by Individual Type
  • For-Profit Organization
  • Nonprofit Organization
  • Health Professional
  • Education Professional

Any nonprofit or for-profit organization, company or institution engaged in biomedical research.

How to Apply

Award Procedure

All accepted applications are evaluated by an appropriate initial review group (study section). All grant applications receive a final secondary review by the National Heart, Lung, and Blood Advisory Council. Staff inform applicants of the results of the review. If support is contemplated, staff initiate preparation of awards for grants.

Decision Timeline

  • Approval: > 180 Days
  • Renewal interval: > 180 Days

Regular Grants: From 7 to 9 months.

Program details & compliance

Description

The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, blood, and sleep conditions and enhance the health of all individuals so that they can live longer and more fulfilling lives. NHLBI supports institutional training programs to develop scientific investigators in these areas.

Mission Categories

Primary: Prevention and Control (includes Suicide Prevention)

Use of Funds

Allowed Uses

Grants may support stipends, research expenses, supplies, travel, childcare costs, and research training tuition as required to perform the research effort. Individual predoctoral and postdoctoral national research service awards (NRSAs) are made directly to individuals through their universities for research training in heart and vascular diseases. NRSA awards may be made to eligible institutions to enable them to appoint individuals selected by the institution for research training. Certain service and payback provisions may apply to postdoctoral individuals upon termination of the award or termination of the appointment.

Restrictions

Restrictions or limitations are imposed against the use of funds for entertainment, foreign travel, general-purpose equipment, alterations and renovations, and other items not regularly required for the performance of research.

Required Documentation

Individual NRSA awardees and Institutional NRSA trainees must be citizens or noncitizen nationals of the United States or have been admitted for permanent residency. Two levels of training are available: graduate level predoctoral training and postdoctoral training. All potential trainees must possess a desire for training in one of the health or health-related areas specified by the National Institutes of Health. Each applicant must be sponsored by an accredited public or private nonprofit institution engaged in such training. Costs will be determined in accordance with OMB Circular No. A-87 for State and local governments. For-profit organization costs are determined in accordance with Subpart 31.2 of the Federal Acquisition Regulations. For other grantees, costs will be determined in accordance with DHHS Regulations 45 CFR, Part 74, Subpart Q. Electronic submission of NIH Research Performance Progress Reports (RPPR) applies to non-competing continuations. OMB Circular No. A-87 applies to this program. 2 CFR 200, Subpart E - Cost Principles applies to this program. 2 CFR 200, Subpart E - Cost Principles applies to this program. 2 CFR 200, Subpart E - Cost Principles applies to this program.
2 CFR 200, Subpart E - Cost Principles applies to this program.

Reporting & Compliance

Audit Required
Yes — Determined at Time of Award
Records Retention
3 years

Applicable 2 CFR 200 Subparts

  • Subpart B — General Provisions
  • Subpart C — Pre-Federal Award Requirements
  • Subpart D — Post-Federal Award Requirements
  • Subpart E — Cost Principles
  • Subpart F — Audit Requirements

Contacts

Kelly Barford
301.594.4600
National Heart, Lung, and Blood Institute (NHLBI), Bethesda, MD 20817
Christine Cullinane — NHLBI Referral Officer
3018277944
National Heart, Lung, and Blood Institute (NHLBI), Bethesda, MD 20817
Data from SAM.gov Federal Assistance Listings. Source published: 2026-02-03. Spec v2.0. Last synced: 2026-05-29 05:37:31.